After three years, about 9% saw cancer come back, similar to the rate seen in a set of similar women in a separate study who stayed on hormone-blocking therapy. There were nine deaths, “below expected rates for this population,” Partridge said.
“He’s perfect in every way,” Bianchi said. “I couldn’t imagine my life without him. We couldn’t imagine our family without him.” “If I had listened to the first few doctors or oncologists that I spoke with, I would have lost all my hope,” said Bianchi, 42, of Niskayuna, New York. “I would have very quickly accepted that I would never have the family that I had envisioned.”She was able to breastfeed her son for six months before resuming hormone-blocking therapy, which she’ll continue until 2026.
An interesting new drug, not yet tested on younger breast cancer patients -